Literature DB >> 7426314

Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.

Y C Taylor, A M Rauth.   

Abstract

Equimolar concentrations of cysteamine and reduced glutathione protected against the cytotoxicity of 5 mM misonidazole (MISO), whereas 5mM ascorbate enhanced its toxicity to hypoxic CHO and HeLa cells in vitro. Protection (reappearance of a shoulder region) could also be seen when cysteamine was added at later incubation times. These changes in toxicity were accompanied by changes in drug metabolism, as evidenced by radiochromatograms of cell extracts obtained after treatment with 14C-labelled MISO. In contrast, radiochromatograms obtained from cells treated with toxic levels of MISO (75 mM) under aerobic conditions indicated no drug metabolism. Both toxicity and drug metabolism could be immediately halted by introducing O2 during hypoxic exposure to MISO. These observations are discussed in terms of a possible model for the metabolism-mediated toxicity of MISO and the roles which sulphydryls and O2 may play.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426314      PMCID: PMC2010364          DOI: 10.1038/bjc.1980.166

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Hypoxic sensitizers: radiobiological studies at the cellular level.

Authors:  E J Hall; L Roizin-Towle
Journal:  Radiology       Date:  1975-11       Impact factor: 11.105

2.  Interaction with drugs and environmental chemicals. Effects of ascorbic acid on microsomal drug metabolism.

Authors:  V G Zannoni; P H Sato
Journal:  Ann N Y Acad Sci       Date:  1975-09-30       Impact factor: 5.691

3.  Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells.

Authors:  B A Moore; B Palcic; L D Skarsgard
Journal:  Radiat Res       Date:  1976-09       Impact factor: 2.841

4.  Ro-07-0582 as a radiosensitizer and cytotoxic agent.

Authors:  E J Hall; J Biaglow
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 May-Jun       Impact factor: 7.038

5.  Ascorbate-enhanced cytotoxicity of misonidazole.

Authors:  P D Josephy; B Palcic; L D Skarsgard
Journal:  Nature       Date:  1978-01-26       Impact factor: 49.962

6.  Hypoxic cell sensitisers in radiotherapy.

Authors:  S Dische
Journal:  Int J Radiat Oncol Biol Phys       Date:  1978 Jan-Feb       Impact factor: 7.038

7.  Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo.

Authors:  A J Varghese; S Gulyas; J K Mohindra
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

8.  Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.

Authors:  R C Urtasun; P Band; J D Chapman; H R Rabin; A F Wilson; C G Fryer
Journal:  Radiology       Date:  1977-03       Impact factor: 11.105

9.  Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.

Authors:  I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

10.  Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine.

Authors:  E J Hall; M Astor; C Geard; J Biaglow
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

View more
  8 in total

Review 1.  Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.

Authors:  Peter Wardman
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

2.  Hydroethidine: a fluorescent redox probe for locating hypoxic cells in spheroids and murine tumours.

Authors:  P L Olive
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

3.  Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S.

Authors:  E O Pettersen; T Lindmo
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

Review 4.  The experimental development of bioreductive drugs and their role in cancer therapy.

Authors:  P Workman; I J Stratford
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

5.  Selective toxicity of nitracrine to hypoxic mammalian cells.

Authors:  W R Wilson; W A Denny; S J Twigden; B C Baguley; J C Probert
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

6.  Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitro.

Authors:  B C Millar; S Jinks; T J Powles
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

7.  In vitro metabolism of misonidazole.

Authors:  P D Josephy; B Palcic; L D Skarsgard
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

8.  Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.

Authors:  E Smith; I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.